We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Treatment INDs: Research for Hire?

Grace Powers Monaco, JD; M. Gail Gottlieb
JAMA. 1987;258(22):3296-3297. doi:10.1001/jama.1987.03400220096045.
Text Size: A A A
Published online


THE FOOD and Drug Administration (FDA) has finalized new rules to facilitate the availability, outside of clinical trials, of promising new therapies being investigated in clinical trials. Effective June 22, 1987, investigational new drugs (INDs) have been available to treat "desperately" ill patients (those patients with serious or immediately life-threatening illnesses) as early in the drug development phase as possible. These new therapeutic options are referred to as "treatment INDs.1 Patient access to these drugs, usually limited to clinical trials, is conditioned on an absence of comparable or satisfactory therapy and on adequate enrollment in ongoing clinical trials.

The FDA postulates that requiring adequate clinical trial enrollment before access to treatment INDs is permitted will prevent the undermining of the clinical trial process. Only time will tell whether the trial process will be harmed. However, without this provision, not included in the rule as initially proposed, the FDA would have


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.